A new study has evaluated the effectiveness of different treatment options for basal cell carcinoma. Learn more.

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Clinical Features. Basal cell carcinoma (BCC) is the most common malignant eyelid tumor, accounting for 85% of all such tumors. [1] The tumor usually affects adults but may also occur in younger ...

Skin biopsy specimens of three lesions on her back were consistent with cutaneous T-cell lymphoma (CTCL ... treatment with topical 5% imiquimod cream three times per week was started for 2 ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...

Data from All 50 States Shows Early Onset Breast Cancer Is on the Rise in Younger Women: Does Place of Exposure Matter? Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...

Stem-cell research is the area of research that studies the properties of stem cells and their potential use in medicine. As stem cells are the source of all tissues, understanding their ...

Results at a three-year median follow-up, now published, show: The investigational cancer vaccine activated a T cell response in half of patients (responders), and this response correlated with ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication ...

There are two basic types of lung cancer: small cell (SCLC), the most aggressive type of lung cancer, and non-small cell (NSCLC), the most common type (which includes several subtypes). Rather than ...